 The purpose of this study is to evaluate the safety, tolerability, and feasibility of Blood-Brain Barrier BBB opening using transcranial MRI-guided focused ultrasound in conjunction with an intravenous ultrasound contrast agent in patients with Amyotrophic Lateral Sclerosis ALS. 